D.E. Shaw & Co’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119M | Buy |
|
|||||
|
2025
Q1 | $73.7M | Sell |
|
|||||
|
2024
Q4 | $69.6M | Buy |
|
|||||
|
2024
Q3 | $52.7M | Buy |
|
|||||
|
2024
Q2 | $41.5M | Buy |
|
|||||
|
2024
Q1 | $35.7M | Sell |
|
|||||
|
2023
Q4 | $37.1M | Buy |
|
|||||
|
2023
Q3 | $18.8M | Buy |
|
|||||
|
2023
Q2 | $29.8M | Buy |
|
|||||
|
2023
Q1 | $34.2M | Sell |
|
|||||
|
2022
Q4 | $36.1M | Sell |
|
|||||
|
2022
Q3 | $52.9M | Buy |
|
|||||
|
2022
Q2 | $38.2M | Sell |
|
|||||
|
2022
Q1 | $38.7M | Sell |
|
|||||
|
2021
Q4 | $47.6M | Sell |
|
|||||
|
2021
Q3 | $44.6M | Sell |
|
|||||
|
2021
Q2 | $51.1M | Buy |
|
|||||
|
2021
Q1 | $55.4M | Buy |
|
|||||
|
2020
Q4 | $59.4M | Buy |
|
|||||
|
2020
Q3 | $41.1M | Sell |
|
|||||
|
2020
Q2 | $45.4M | Sell |
|
|||||
|
2020
Q1 | $44.4M | Sell |
|
|||||
|
2019
Q4 | $50.9M | Buy |
|
|||||
|
2019
Q3 | $27.4M | Sell |
|
|||||
|
2019
Q2 | $37.7M | Sell |
|
|||||
|
2019
Q1 | $33.2M | Sell |
|
|||||
|
2018
Q4 | $34.2M | Sell |
|
|||||
|
2018
Q3 | $82.6M | Sell |
|
|||||
|
2018
Q2 | $80.5M | Buy |
|
|||||
|
2018
Q1 | $63.1M | Sell |
|
|||||
|
2017
Q4 | $43.5M | Buy |
|
|||||
|
2017
Q3 | $47.3M | Sell |
|
|||||
|
2017
Q2 | $49.9M | Buy |
|
|||||
|
2017
Q1 | $19.5M | Buy |
|
|||||
|
2016
Q4 | $16.4M | Buy |
|
|||||
|
2016
Q3 | $10.5M | Buy |
|
|||||
|
2016
Q2 | $202K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $534K | Sell |
|
|||||
|
2015
Q3 | $1.44M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $253K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $635K | Buy |
|